Bristol Myers Squibb to Present Data Across Cardiovascular Portfolio at the European Society of Cardiology Congress 2024Business Wire • 08/26/24
Bristol Myers Squibb Receives U.S. Food and Drug Administration sBLA Acceptance for First-Line Treatment of Unresectable Hepatocellular CarcinomaBusiness Wire • 08/21/24
Bristol Myers' (BMY) Breyanzi Label Expansion Application ValidatedZacks Investment Research • 08/20/24
3 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a DecadeThe Motley Fool • 08/20/24
European Medicines Agency Validates Bristol Myers Squibb's Application for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular LymphomaBusiness Wire • 08/19/24
All You Need to Know About Bristol Myers (BMY) Rating Upgrade to BuyZacks Investment Research • 08/15/24
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement of its Treg Cell Therapy Pipeline into Clinical DevelopmentGlobeNewsWire • 08/15/24
Bristol Myers (BMY) Gains 16% in a Month: Should You Buy or Wait?Zacks Investment Research • 08/12/24
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.The Motley Fool • 08/05/24
Bristol Myers Squibb (BMY) Crossed Above the 200-Day Moving Average: What That Means for InvestorsZacks Investment Research • 08/02/24
Dividend Harvesting Portfolio Week 178: $17,800 Allocated, $1,612.87 In Projected DividendsSeeking Alpha • 08/01/24